|
ZNF407 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.86208859232329E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.38429967278375E-10 |
| Normal-vs-Stage2 |
7.97559999999864E-05 |
| Normal-vs-Stage3 |
1.79570025515829E-10 |
| Normal-vs-Stage4 |
3.55339979662972E-10 |
| Stage1-vs-Stage2 |
4.793000E-01 |
| Stage1-vs-Stage3 |
2.658000E-01 |
| Stage1-vs-Stage4 |
5.432400E-02 |
| Stage2-vs-Stage3 |
1.575240E-01 |
| Stage2-vs-Stage4 |
5.766100E-02 |
| Stage3-vs-Stage4 |
4.397000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64113167500091E-12 |
| Normal-vs-AfricanAmerican |
1.423720E-02 |
| Normal-vs-Asian |
1.95839999994618E-07 |
| Caucasian-vs-AfricanAmerican |
3.263900E-02 |
| Caucasian-vs-Asian |
9.642200E-01 |
| AfricanAmerican-vs-Asian |
6.270000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.61169991083921E-10 |
| Normal-vs-Female |
3.46429551711935E-11 |
| Male-vs-Female |
7.229000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.10899994637737E-09 |
| Normal-vs-Age(41-60Yrs) |
6.8365002547921E-10 |
| Normal-vs-Age(61-80Yrs) |
7.52439999196497E-10 |
| Normal-vs-Age(81-100Yrs) |
1.715050E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.440600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.956600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.541200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.872600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.306800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.165200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.954600E-04 |
| Classical-VS-Follicular |
2.954200E-01 |
| Classical-VS-Other |
9.783600E-02 |
| Classical-VS-Normal |
1.35809996582026E-09 |
| Tall-VS-Follicular |
2.706200E-02 |
| Tall-VS-Other |
7.757400E-01 |
| Tall-VS-Normal |
4.59300375510452E-11 |
| Follicular-VS-Other |
2.481600E-01 |
| Follicular-VS-Normal |
7.63999999930931E-08 |
| Other-VS-Normal |
3.626200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.26339946785004E-10 |
| Normal-vs-N1 |
4.88380447194459E-11 |
| N0-vs-N1 |
3.007600E-02 |
|
|
